Main
>
GASTROENTEROLOGY
>
Inflammatory Bowel Disease (IBD)
>
Treatment
>
RNA Blocking Drug
>
Co.: Sweden. I (Development)
>
Status: Phase II
Status: Phase II's products
This section has no products